Insulet Corporation - Common Stock (NQ:PODD)

142.31 +1.15 (+0.81%)

Streaming Delayed Price Updated: 10:11 AM EDT, Aug 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

24 25 Next >

Which S&P500 stocks are moving on Wednesday? ↗

April 29, 2026

Via Chartmill

Insulet to Participate in BofA Securities 2026 Health Care Conference

April 28, 2026

From Insulet Corporation

Via Business Wire

1 Oversold Stock Primed to Rebound and 2 We Ignore

April 28, 2026

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a co...

Via StockStory

2 of Wall Street’s Favorite Stocks for Long-Term Investors and 1 We Turn Down

April 27, 2026

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

Via StockStory

Topics Retirement

Insulet Corp (NASDAQ:PODD): A Prime GARP Investment with Strong Growth and Reasonable Valuation ↗

April 02, 2026

Via Chartmill

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

April 21, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

April 14, 2026

From Pomerantz LLP

Via GlobeNewswire

2 High-Flying Stocks to Own for Decades and 1 We Turn Down

April 09, 2026

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lo...

Via StockStory

Topics Supply Chain

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

April 07, 2026

From Pomerantz LLP

Via GlobeNewswire

Insulet (PODD): 3 Reasons We Love This Stock

April 03, 2026

What a brutal six months it’s been for Insulet. The stock has dropped 33.8% and now trades at $204.57, rattling many shareholders. This may have investors wo...

Via StockStory

Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring

April 02, 2026

Shares of Eli Lilly and Company (NYSE: LLY) surged 3.8% on Wednesday following the milestone FDA approval of Foundayo (orforglipron), the first once-daily oral weight-loss pill that does not require...

Via MarketMinute

Topics Economy

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

April 01, 2026

From Insulet Corporation

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

March 31, 2026

From Pomerantz LLP

Via GlobeNewswire

What's going on in today's pre-market session: S&P500 movers ↗

March 31, 2026

Via Chartmill

Winners And Losers Of Q4: Insulet (NASDAQ:PODD) Vs The Rest Of The Patient Monitoring Stocks

March 30, 2026

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including Insulet (NASDAQ:PODD) and its peers. Patient m...

Via StockStory

Topics Artificial Intelligence

Insulet Appoints Mike Panos as Chief Commercial Officer

March 30, 2026

From Insulet Corporation

Via Business Wire

PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm

March 28, 2026

From The Schall Law Firm

Via Business Wire

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Via StockStory

Topics Artificial Intelligence Government Stocks

3 S&P 500 Stocks for Long-Term Investors

March 27, 2026

The S&P 500 (^GSPC) is full of established businesses, but only some continue to outperform the market. A few standout companies are thriving thanks to stron...

Via StockStory

Topics Stocks

Stay informed with the top movers within the S&P500 index on Wednesday. ↗

March 25, 2026

Via Chartmill

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

March 24, 2026

From Pomerantz LLP

Via GlobeNewswire

Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

March 19, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

March 18, 2026

From Law Offices of Frank R. Cruz

Via Business Wire

Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

March 18, 2026

From Law Offices of Howard G. Smith

Via Business Wire

1 Healthcare Stock with Exciting Potential and 2 We Avoid

March 18, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...

Via StockStory

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

March 17, 2026

From Pomerantz LLP

Via GlobeNewswire

This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗

March 15, 2026

EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships.

Via The Motley Fool

This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗

March 15, 2026

This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide.

Via The Motley Fool

Topics Regulatory Compliance

EXCLUSIVE: Just 5 Female CEOs In A 50-Stock ETF — C-Suite Execs Explain The Leadership Gap In Corporate America ↗

March 14, 2026

-link data-ticker=GOOGL data-exchange=NASDAQ href=https://www.benzinga.com/quote/GOOGL target=_blank rel=noopener>(NASDAQ: GOOGL), One week after we celebrated the International Women's day, here is a...

Via Benzinga

Topics ETFs Stocks

Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

March 13, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.